New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For JBL;ARRS;GOOG;NYX;ICE;SD;ACN;BBBY;FOLD;GSK;MDRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
March 31, 2015
06:16 EDTGOOGAT&T rolls out high-speed internet in Cupertino, WSJ says
Subscribe for More Information
March 30, 2015
14:38 EDTGOOGGoDaddy IPO has many red flags, PandoDaily says
GoDaddy (GDDY) is expected to launch its IPO this week, with a range of $17-$19 per share, valuing the company at $2.7B assuming the midpoint of that range. However, PandoDaily sees a number of red flags for the IPO, including competition with Google (GOOG), a "dying market with low margins," a history of losses, heavy debt, and awkward timing for the IPO. Reference Link
12:52 EDTGOOGGoogle says aware of problem with Gmail for 'significant' number of users
Google (GOOG, GOOGL) stated in a service notice update: "We're aware of a problem with Gmail affecting a significant subset of users. The affected users are able to access Gmail, but are seeing error messages and/or other unexpected behavior. We will provide an update by 3/30/15, 1:15 PM detailing when we expect to resolve the problem. Please note that this resolution time is an estimate and may change. This is only affecting IMAP connections to Gmail." Reference Link
12:22 EDTBBBYBed Bath & Beyond April volatility elevated into Q4 and outlook
Subscribe for More Information
09:40 EDTGOOGWeb.com may see larger threat from GoDaddy than Google, says BWS Financial
Subscribe for More Information
07:38 EDTGOOGSenate to investigate FTC decision to not sue Google, NY Post says
Subscribe for More Information
06:03 EDTGOOGU.K. court to allow privacy lawsuit against Google, FT says
Subscribe for More Information
March 29, 2015
15:46 EDTGSKGSK reaches agreement with UK on meningitis B vaccine
Subscribe for More Information
March 27, 2015
19:00 EDTGOOGMicrosoft, Yahoo extend search partnership discussions for 30 days
Subscribe for More Information
15:14 EDTGOOGJohnson & Johnson not likely to buy Intuitive Surgical, says BofA/Merrill
Subscribe for More Information
09:59 EDTGOOGJohnson & Johnson to collaborate with Google to advance surgical robots
Subscribe for More Information
08:03 EDTGOOGYouTube experiments with ultra-high-def video, TechCrunch says
Subscribe for More Information
05:57 EDTGOOGMicrosoft to push 2 inexpensive notebooks in mid-2015, DigiTimes says
Subscribe for More Information
March 26, 2015
16:20 EDTACNOn The Fly: Closing Wrap
Subscribe for More Information
16:02 EDTACNAccenture unit completes acquisition of Agilex Technologies
Accenture Federal Services said it has completed its acquisition of Agilex Technologies, a provider of digital solutions for the U.S. federal government. The acquisition was first announced on February 9.
14:10 EDTACNAccenture price target range raised to $101-$103 at Wells Fargo
Subscribe for More Information
12:27 EDTACNOn The Fly: Midday Wrap
Subscribe for More Information
12:17 EDTGOOGEarnings Preview: Analyst sees BlackBerry's revenue bottoming in Q4
Subscribe for More Information
11:37 EDTGOOGAnalyst says preliminary Google click data looks negative
Subscribe for More Information
11:13 EDTGSKBofA/Merrill European pharma analyst holds an analyst/industry conference call
Subscribe for More Information
10:36 EDTGOOGGoogle paid clicks growth slowed in Q1, says Axiom
Subscribe for More Information
09:27 EDTGOOGGoogle expands product ratings in search results to U.K., France, Germany
In a blog post, Google reported it is expanding its "product ratings" advertisement feature to the U.K., France, and Germany. The feature appends customer reviews to product ads that appear in search results. Reference Link
09:23 EDTACNOn The Fly: Pre-market Movers
Subscribe for More Information
08:40 EDTGOOGFTC responds to recent Google reports, calls claims of impropriety factless
In a statement released yesterday, the Federal Trade Commission responded to recent news regarding its 2012 antitrust investigation of Google. The Commission stated the inadvertently disclosed memo is "only a fraction [of the total documents that were reviewed.] As we stated when the investigation was closed, the Commission concluded that Google’s search practices were not, 'on balance, demonstrably anticompetitive.' Contrary to recent press reports, the Commission’s decision on the search allegations was in accord with the recommendations of the FTC’s Bureau of Competition, Bureau of Economics, and Office of General Counsel. Some of the FTC’s staff attorneys on the investigation raised concerns about several other Google practices. In response, the Commission obtained commitments from Google regarding certain of those practices. Over the last two years, Google has abided by those commitments... On the same day that it closed the search investigation, the Commission settled a complaint alleging that Google’s conduct with regard to certain standard essential patents constituted unfair methods of competition under the FTC Act. The Wall Street Journal article 'Google Makes Most of Close Ties to White House' makes a number of misleading inferences and suggestions about the integrity of the FTC’s investigation. The article suggests that a series of disparate and unrelated meetings involving FTC officials and executive branch officials or Google representatives somehow affected the Commission’s decision to close the search investigation in early 2013. Not a single fact is offered to substantiate this misleading narrative. Finally, we regret the inadvertent disclosure of confidential documents and information in response to a Freedom of Information Act request. We are taking additional steps to ensure that such a disclosure does not occur in the future."
08:26 EDTACNAccenture management to meet with Deutsche Bank
Meeting to be held in Boston on March 26 hosted by Deutsche Bank.
07:25 EDTGOOGThe Economist to hold a forum
Subscribe for More Information
07:14 EDTACNAccenture reports Q2 new bookings $9.4B
"Based on our continued momentum and very strong performance in the first half, we are raising our business outlook for revenues for the full fiscal year," said the company.
07:12 EDTACNAccenture sees FY15 adjusted EPS to $4.66-$4.76, consensus $4.75
Accenture now expects GAAP EPS to be $4.61-$4.71, including the positive impact of its increased revenue outlook, offset by negative impact of revised foreign-exchange assumption, as well as negative impact of settlement charge. Company’s previously guided EPS was $4.66-$4.80. Company raises FY15 net revenue growth in local currency 8%-10% from 5%-8%. FY15 outlook now assumes forex impact (8%); previous assumption was (5%). In May, company will record non-cash settlement charge of approximately $60M, pre-tax, as a result of a current offer to former employees to receive a voluntary one-time, lump-sum cash payment from company’s U.S. pension plan. The payment will settle the company’s pension obligations. This settlement charge will reduce company’s fiscal 2015 GAAP EPS by approximately 5c and full-year GAAP operating margin by approximately 20 basis points. Accenture now expects GAAP operating margin for the full fiscal year to be 14.2%-14.4%, compared with previously guided 14.4%-14.6%. Excluding the settlement charge, operating margin for full fiscal year expected to be 14.4%-14.6%, an expansion of 10 to 30 basis points from fiscal 2014. Now expects operating cash flow for fiscal 2015 to be $3.85B to $4.15B, compared with $3.95B to $4.25B previously; continues to expect property and equipment additions to be $450M; and now expects free cash flow to be $3.4B to $3.7B, compared with $3.5B to $3.8B previously. The company continues to expect to return at least $3.8B to its shareholders in fiscal 2015 through dividends and share repurchases. The company continues to expect its annual effective tax rate to be in the range of 26% to 27%. Accenture is now targeting new bookings for fiscal 2015 in the range of $33B to $35B, compared with $34B to $36B previously, reflecting its revised foreign-exchange assumption.
07:06 EDTACNAccenture declares semi-annual cash dividend of $1.02
Subscribe for More Information
07:05 EDTACNAccenture sees Q3 revenue $7.35B-$7.6B, consensus $7.63B
Subscribe for More Information
07:04 EDTACNAccenture reports Q2 EPS $1.08, consensus $1.07
Reports Q2 revenue $7.49B, consensus $7.38B.
06:59 EDTGOOGFacebook video outpaces YouTube in recent metrics, BI says
Subscribe for More Information
06:41 EDTGOOGTwitter to outpace Yahoo in display ad revenue, WSJ says
Subscribe for More Information
06:05 EDTGOOGIntel to partner with notebook makers for Chromebook 2-in-1s, DigiTimes says
Subscribe for More Information
March 25, 2015
15:34 EDTACNNotable companies reporting before tomorrow's open
Subscribe for More Information
10:36 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD WLL WBAI ASPS GES PSEC CTRP LNCO VRTX ARP
09:01 EDTACNAccenture March weekly volatility elevated into Q2 and outlook
Accenture March weekly call option implied volatility is at 77, April is at 27, May is at 21, August is at 19; below its 26-week average of 19 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on March 26.
08:58 EDTICEHouse Agriculture Committee to hold a hearing
Subscribe for More Information
06:54 EDTGOOGPotential YouTube competitor launches, Variety says
Digital subscription video start-up Vessel, which is looking to compete with Google's (GOOG) YouTube, launched yesterday, according to Variety. Vessel was founded by Jason Kilar, the founding CEO of Hulu, the magazine stated. Disney (DIS), 20th Century Fox (FOX, FOXA), and Comcast (CMCSA) own stakes in Hulu. Reference Link
06:46 EDTGOOGGoogle visited White House 230 times during Obama administration, WSJ
Google employees have visited the White House to meet with senior officials roughly 230 times -- averaging once per week -- since President Obama took office, reports the Wall Street Journal, citing visitor logs and emails. CEO Larry Page met with FTC officials and Chairman Eric Schmidt met with a senior presidential adviser during the 2012 Google antitrust investigation, which was closed soon after the meetings. The Journal notes that on November 6, 2012, Schmidt personally oversaw a voter-turnout platform for Obama -- by the end of the month, the FTC had closed their investigation into the company. Reference Link
06:02 EDTGOOGYouTube to relaunch livestreaming platform, Daily Dot says
Subscribe for More Information
March 24, 2015
16:20 EDTGOOGOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTGOOGOptions Update; March 24, 2015
iPath S&P 500 VIX Short-Term Futures down 10c to 25.14 Option volume leaders: AAPL TSLA TWTR GILD FB AMAT GOOG C MRK GILD according to Track Data.
15:33 EDTGOOGGoogle working on project to add bill pay function to Gmail, Re/code reports
Subscribe for More Information
10:17 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR GES VHC CTRP WSM WLL LNCO NLY ORCL
09:38 EDTGOOGActive equity options trading on open
Subscribe for More Information
09:09 EDTGOOGMorgan Stanley CFO Porat to join Google as new CFO
Google (GOOG, GOOGL) and Morgan Stanley (MS) this morning announced that current Morgan Stanley Chief Financial Officer Ruth Porat will leave the firm and take on the same role at Google. WHAT'S NEW: Morgan Stanley said in a filing that Porat, who joined the firm in 1987, will leave the company, effective April 30. At Morgan Stanley, Porat was previously vice chairman of Investment Banking, global head of the Financial Institutions Group and and co-head of Technology Investment Banking. Google said in a separate statement that Porat will join the company as CFO on May 26. At Google, Porat will report to Google Chief Executive Officer and co-founder, Larry Page. WHAT'S NOTABLE: Jonathan Pruzan, currently co-head of the Global Financial Institutions Group in Investment Banking at Morgan Stanley, will succeed Porat as the bank's CFO upon Porat's departure. PRICE ACTION: Morgan Stanley is down 0.14% in pre-market trading and Google is up 1.09%.
08:59 EDTGOOGMorgan Stanley confirms Jonathan Pruzan will succeed Ruth Porat as CFO
Morgan Stanley (MS) announced in a filing that Ruth Porat, executive VP and CFO, would leave the company on April 30. In a memo, CEO James Gorman says, "After a 28-year career at Morgan Stanley, Ruth Porat has decided to leave the Firm to take on a new role in Silicon Valley and return to her California roots. It is with a heavy heart that we see her go. Ruth joined Morgan Stanley in 1987 and has played a number of key roles at the Firm, from her time leading the tech banking franchise during the Internet boom, to leading the FIG banking team during the financial crisis, then as CFO partnering with the senior team to transform Morgan Stanley for the new regulatory environment. She has been a mentor and sponsor to many colleagues, and a role model for even more. Her tremendous energy, diligence and insight have been an enormous asset to the Firm... Jonathan Pruzan, currently Co-Head of the Global Financial Institutions Group in Investment Banking, will be appointed CFO upon Ruth’s departure. Jon joined Morgan Stanley in 1994 and has spent more than 20 years at the Firm working with financial institution clients. He understands the current regulatory environment, having shepherded clients through the Fed’s stress test and CCAR processes. He brings both great technical skill and proven leadership to this new role. Jon has served on the Morgan Stanley/MUFG steering committee since 2013 and will continue to do so. He will join the Firm’s Operating Committee and Management Committee."
08:57 EDTGOOGGoogle confirms that Morgan Stanley's Ruth Porat to join company as CFO
Subscribe for More Information
08:55 EDTGOOGGoogle to name Ruth Porat as CFO, Bloombeg reports
Dow Jones previously reported that Porat is leaving Morgan Stanley (MS).
08:13 EDTMDRXAllscripts extends agreement with Drexel University
Drexel University College of Medicine renewed its agreement with Allscripts and the use of Allscripts TouchWorks EHR as its core electronic health record, or EHR, solution. In addition, Drexel implemented the Allscripts FollowMyHealth as its patient engagement platform. Drexel intends to leverage Allscripts solutions to help meet Meaningful Use requirements, support its mission of education and research, and continue to deliver high quality patient care for the communities it serves. Drexel's renewal extends an innovative relationship that began in 2004.
07:45 EDTGSKFDA Pediatric Advisory Committee holds a meeting
The Committee discusses pediatric-focused safety reviews, as mandated by the FDA Safety and Innovation Act (FDASIA) for Eli Lilly's Cymbalta, Pfizer's Quillivant XR and Revatio, Johnson & Johnson's Risperdal, GlaxoSmithKline's Advair, HFA Altabax Ointment and Fluarix Quadrivalent, Supernus Pharmaceuticals' Oxtellar XR, Teva Pharmaceutical's Qnasl and Roche's Invirase. The Committee will also discuss the safety ongoing propriety of the humanitarian device exemption for the Medtronic Activa Dystonia Therapy and for the Liposorber LA-15 System in a meeting being held in Silver Spring, Maryland on March 24 at 8 am. Webcast Link
06:42 EDTGOOGGoogle to start showing TV ads to Google Fiber customers, NY Times says
Google said it would soon begin showing local, targeted TV ads to customers of its Google Fiber service in Kansas City, Kansas and Kansas City, Missouri, according to The New York Times, which cited a letter that Google sent to its customers in those cities. Reference Link
05:58 EDTGOOGGoogle partners with Taiwan banks to nurture marketing talent, DigiTimes reports
Subscribe for More Information
March 23, 2015
11:22 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR RUSL XONE GES CTRP WSM NLY ADBE ORCL
10:32 EDTGOOGApple positioned to reach $1 trillion market cap, Cantor says
Subscribe for More Information
09:45 EDTGSKUBS to hold a field trip
Subscribe for More Information
09:29 EDTGOOGGoogle's Eric Schmidt says Google Glass is long-term project, WSJ reports
Google Executive Chairman Eric Schmidt said Google Glass is too important of a technology to scrap, reports the Wall Street Journal. Although Google stopped selling the first version of Glass, shut down its Explorer program, and made personnel changes, Schmidt said Google Glass remains a "big and very fundamental platform" for the company and will be a long-term project. Reference Link
08:13 EDTGOOGPendrell unit: Court rejects attempts to limit scope of DRM patents
ContentGuard Holdings, a subsidiary of Pendrell Corporation (PCO), announced that on Friday, March 20, Judge J. Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas issued a 144 page Claim Construction Order in lawsuits ContentGuard filed against several companies who continue to use its patented Digital Rights Management solutions without a license, including Apple (AAPL), Amazon.com (AMZN), DirecTV (DTV), Google (GOOG), HTC, Huawei, Motorola Mobility and Samsung Electronics (SSNLF). In his order, Judge Gilstrap interpreted the language in ContentGuard’s patents in a manner that fully preserves the breadth of ContentGuard’s patented Digital Rights Management technologies. These technologies were developed to enable the distribution of digital media over the Internet and other networks, including cellular and satellite networks, and provide innovative solutions to problems that were once thought to be unsolvable. “We are very pleased with the Court’s ruling,” commented James Baker, ContentGuard’s Vice President for Licensing and Strategic Development. “We believe these claim constructions demonstrate that the online stores defendants provide for buying and renting DRM-protected movies, videos, books, and music and devices that play, run, display or print this DRM-protected content infringe ContentGuard’s pioneering DRM patents.”
07:36 EDTGSKPfizer should rise 'significantly' over next two years, says Jefferies
Jefferies analyst Jeffrey Holford told investors this morning that he expects shares of Pfizer (PFE) to appreciate "significantly" over the next two years. A survey of U.S. oncologists indicated the company's Ibrance drug will be used in 50% of first line hormonal therapy within one year, with off-label use in all lines of therapy including adjuvant, Holford noted. He thinks peak sales of the drug could top $13B, which is well above consensus. In addition, the analyst views Pfizer's Global Established Pharmaceutical business as being underappreciated by the market. Potential value creating options for the pharmaceutical giant include spinning off its GEP unit by 2017 and accretive acquisitions, with possible takeover targets being Shire (SHPG), Actavis (ACT), AstraZeneca (AZN) and GlaxoSmithKline (GSK), in the eyes of Holford. He added the stock to the firm's Franchise Picks list, which encompasses its best ideas. He also raised his price target for Pfizer to $45 from $42. The stock closed Friday up 10c to $34.25.
06:47 EDTGOOGFTC staffers' position on Google may affect EU outlook, WSJ says
Subscribe for More Information
06:00 EDTGOOGGoogle dives deeper into health data gathering, Financial Times reports
Google is diving deeper into the health sector, placing a series of bets that include Google Genomics and an investment in 23AndMe, reports the Financial Times. This comes after the company closed its Google Health division a few years ago and CEO Larry Page said regulations about the use of personal health data was holding back medical research. Reference Link
March 22, 2015
17:07 EDTGOOGFTC disclosures embolden potential EU Google probe, WSJ says
Subscribe for More Information
15:17 EDTGSKGSK looks to conclude negotiations with U.K. on vaccine cost, Bloomberg says
Subscribe for More Information
March 20, 2015
12:41 EDTGSKOn The Fly: Midday Wrap
Stocks began the day sharply higher and have continued to tack on gains throughout the morning. The market’s move put the Nasdaq back above 5,000 and the S&P above 2,100. The market is undergoing quadruple witching, which occurs 4 times per year and typically is accompanied by high volume and volatility. ECONOMIC EVENTS: In the U.S., the economic calendar was quiet. The Baker Hughes U.S. rig count, which has been closely watched in recent months amid the protracted slide in oil prices, is expected at 1:00 pm EDT. The count of U.S. rigs stood at 1125 at the end of last week. In Europe, reports indicate German Chancellor Angela Merkel said Greece has agreed to send a list of overhauled reforms to European officials within days. COMPANY NEWS: Shares of Nike (NKE) advanced 4% following its Q3 earnings beat. Credit Suisse raised Nike's price target to $106 following the report, saying Nike's underlying futures growth remains in double-digits and preliminary FY16 guidance suggests management has been effective in managing currency headwinds... The shares of Biogen (BIIB) rallied 8% after the company reported results for an early stage study of its Alzheimer's drug, BIIB-037. The company announced that the three milligram, six milligram, and ten milligram dose versions of its Alzheimer's treatment, aducanumab, had reduced the amount of amyloid plaque in the brains of Alzheimer's patients taking the drug by statistically significant amounts compared with those taking placebos. The cognitive decline of patients taking BIIB-037 was also significantly less than that of patients who were taking placebos, the company reported. MAJOR MOVERS: Among the notable gainers was Prothena (PRTA), which surged 30% after announcing results from a Phase 1 single ascending dose study of its potential treatment of Parkinson's disease. Also higher was Darden Restaurants (DRI), which gained 4% after the owner of the Olive Garden and Long Horn restaurant chains reported earnings that beat expectations. Among the noteworthy losers was China's Youku Tudou (YOKU), which dropped 9% and was downgraded to Sell at Deutsche Bank after the company reported mixed Q4 results. Also lower was Theravance (THRX), which fell 7% after the company and partner GlaxoSmithKline (GSK) announced that an FDA advisory committee voted that the efficacy data for their Breo Ellipta inhaler provides substantial evidence of a clinically meaningful benefit in adults, however it voted against approval for the proposed indication in 12-17 year olds. INDEXES: Near midday, the Dow was up 189.04, or 1.05%, to 18,148.07, the Nasdaq was up 40.24, or 0.81%, to 5,032.62, and the S&P 500 was up 19.54, or 0.94%, to 2,108.81.
10:18 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: NKTR FOLD RUSL RSX ORCL GES CTRP SLXP WSM SPXS
09:47 EDTGSKGlaxoSmithKline, Theravance launch Revlar Ellipta in Italy
In a regulatory filing, GlaxoSmithKline (GSK) and Theravance (THRX) announced the launch of Revlar Ellipta in Italy following the recent approval by the Italian regulatory authorities in December 2014. Relvar is a fixed dose combination of the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. The components will be administered using the Ellipta, a dry powder inhaler. In Italy, the product is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product is appropriate; and for the symptomatic treatment of adults with Chronic Obstructive Pulmonary Disease with a FEV1<70% predicted normal post-bronchodilator with an exacerbation history despite regular bronchodilator therapy.
08:47 EDTACNAccenture March weekly volatility elevated into Q2 and outlook
Accenture March weekly call option implied volatility is at 34, April is at 22, May is at 19, August is at 17; below its 26-week average of 19 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on March 26.
06:16 EDTGOOG2012 antitrust report calls Google harmful to market, WSJ says
Subscribe for More Information
06:04 EDTGOOGGlobal smartphone shipments to reach 1.4B units in 2015, DigiTimes Research says
Global smartphone shipments in 2015 is expected to increase 16.4% to reach 1.40B units, reports DigiTimes Research. The shipment growth is due to higher growth in demand in emerging markets including India, Southeast Asia and Latin America. Android (GOOG) will account for 78.5% of 2015 global smartphone shipments, Apple's (AAPL) iOS 16.6%, Microsoft (MSFT) Windows 4% and BlackBerry (BBRY) 0.6%.Reference Link
March 19, 2015
18:14 EDTGSKGlaxoSmithKline, Theravance announce FDA panel outcome on Breo Ellipta
GlaxoSmithKline (GSK) and Theravance (THRX) announced the outcome of the joint meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee of the United States FDA regarding the supplemental New Drug Application for Breo Ellipta as a once-daily inhaled treatment for asthma in patients aged 12 years and older. The FDA Advisory Committee voted that the efficacy and safety data for FF/VI 100/25 mcg and 200/25 mcg once daily in asthma support approval in adults 18 years of age and older (16 for, 4 against). The Committee voted that the efficacy data provides substantial evidence of a clinically meaningful benefit in adults (18 for, 2 against) and that the safety in this population has been adequately demonstrated (17 for, 3 against). The Committee voted against approval for the proposed indication in 12-17 year olds (2 for, 18 against). The Committee voted that the efficacy data was not sufficient to demonstrate the benefit (4 for, 16 against) and the safety (1 for, 19 against) has not been adequately demonstrated in this sub-population. The Committee recommended that a large LABA safety trial with FF/VI should be required in adults (13 yes, 7 no) and in 12-17 year olds (17 yes, 2 no and 1 no-vote), similar to the ongoing LABA safety trials being conducted as an FDA Post-Marketing Requirement by each of the manufacturers of LABA containing asthma treatments. FDA Advisory Committees provide non-binding recommendations for consideration by the FDA. Based on these opinions and the data presented, the FDA will make its final decision on approval, which is expected on April 30.
16:26 EDTFOLDOn The Fly: Closing Wrap
Stocks on Wall Street opened lower but turned mixed early in the day and remained that way for most of the session. The Dow and S&P spent most of the day deep in negative territory, while the Nasdaq managed to stay just above the flat line. Investors had a chance to digest yesterday’s comments from the Fed and may have re-considered whether it latest policy stance was as dovish as originally believed. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 1K to 291K in the week ended March 14, which nearly matched the consensus 293K forecast. The current account deficit widened to $113.5B in Q4 from a revised deficit of $98.9B in Q3. The leading indicators for February rose 0.2% to 121.4, which was in-line with expectations. The Philadelphia Fed business outlook survey ticked down to a 5.0 one-year low from 5.2 in February, missing expectations for it to have risen a 7.0 reading. COMPANY NEWS: Apple (AAPL) joined the Dow Jones Industrial Average after the close last night, replacing AT&T (T). Shares of Apple finished their first day in the blue chip index down 97c, or 0.76%, at $127.50, while AT&T fell 39c, or 1.16%, to $33.20... Coffee giant Starbucks (SBUX) rose $1.92, or 2%, to close at $97.76 after hitting a new all-time high of $99.20 earlier. The move follows the company's investor day meeting yesterday, where it unveiled plans for two pilots of delivery services, reported a partnership to expand the distribution of its ready-to-drink products in China, and announced that its board has declared the sixth two-for-one split of the company’s stock since its IPO in 1992. Goldman Sachs and Wells Fargo were both unphased by the record highs and predicted the rally is not over for Starbucks in upbeat notes on the stock today. MAJOR MOVERS: Among the notable gainers was Amicus Therapeutics (FOLD), which rose $3.11, or 33.26%, to $12.46 after reporting positive results in meetings with the EMA and FDA. Also higher was Wynn Resorts (WYNN), which gained $7.19, or 5.85%, to $130.11 after research firm Brean Capital last night initiated coverage of the stock and several casino peers with Buy ratings. Among the noteworthy losers was Transocean (RIG), which fell $1.09, or 7.15%, to $14.16 after saying that it intends to scrap four rigs and noting that with those it has announced plans to scrap a total of 16 floaters. Also lower after its earnings report was diversified apparel company Vince Holding (VNCE), which fell $3.50, or 16.36%, to $17.89. INDEXES: The Dow fell 117.16, or 0.65%, to 17,959.03, the Nasdaq gained 9.55, or 0.19%, to 4,992.38, and the S&P 500 declined 10.23, or 0.49%, to 2,089.27.
15:35 EDTGOOGKey FTC staff wanted to sue Google on antitrust charges, WSJ says
Subscribe for More Information
15:12 EDTGSKFDA panel says Breo lacks efficacy data in children with asthma, Bloomberg says
Subscribe for More Information
11:18 EDTGOOGeBay cut to sell by noted analyst on mounting PayPal competition
Subscribe for More Information
10:42 EDTFOLDOptions with decreasing implied volatility
Subscribe for More Information
10:23 EDTFOLDHigh option volume stocks
Subscribe for More Information
09:37 EDTFOLDActive equity options trading on open
Subscribe for More Information
09:20 EDTFOLDOn The Fly: Pre-market Movers
Subscribe for More Information
09:02 EDTGOOGIntel, Google, TAG Heuer announce Swiss smartwatch collaboration
Subscribe for More Information
08:34 EDTMDRXAllscripts and NoteSwift enter into collaboration agreement
NoteSwift and Allscripts have entered into an agreement for Allscripts to market and resell NoteSwift 2.0 for Allscripts Professional EHR. In response to customer demand, this strategic agreement may help providers reduce the time spent on creating patient documentation by more than half through the use of medical speech recognition.
08:20 EDTFOLDAmicus to host conference call
Subscribe for More Information
07:59 EDTFOLDAmicus NDA submission removes key overhang, says JPMorgan
Subscribe for More Information
07:26 EDTGSKFDA to hold a joint advisory committee meeting
The Pulmonary-Allergy Drugs Advisory Committee and the Drug Safety & Risk Management Advisory Committee discuss the supplemental New Drug Application (sNDA) 204275-S001, for fluticasone furoate and vilanterol dry powder for inhalation (with the brand name of BREO® ELLIPTA®), sponsored by Glaxo Group Limited (d/b/a GSK) for the once-daily treatment for asthma in patients aged 12 years and older in a meeting being held in Gaithersburg, Maryland on March 19 at 8 am. Webcast Link
07:17 EDTARRSStephens to hold a conference
Subscribe for More Information
07:10 EDTGSKTheravance announces trading in common stock halted as FDA meets on sNDA
Subscribe for More Information
06:55 EDTGOOGCertain news agencies form advertising alliance to rival Google, others, BI says
The Guardian, CNN International, The Financial Times , Reuters (TRI) and The Economist are forming an advertising alliance, called Pangaea, in hopes of rivaling Google (GOOG), Facebook (FB), Twitter (TWTR), and LinkedIn (LNKD), reports Business Insider UK. The Financial Times is owned by Pearson (PSO), The Economist Group is 50% owned by Pearson via The Financial Times, and CNN is owned by Time Warner (TWX). Reference Link
06:42 EDTGOOGSafety standards for self-driving cars remain in flux, WSJ says
A 2012 California proposal to create safety standards for self-driving cars has yet to materialize because lawmakers, regulators, researchers, and government agencies do not know how to fully assess the technology, reports the Wall Street Journal. Google and other auto makers want to verify safety themselves, but law firm TroyGould and advocacy group Auto Reliability and Safety say third party testing is necessary, while a UC Berkeley transportation expert called the issue an "open question." The National Highway Traffic Safety Administration plans to test the technology "as it emerges... to inform future federal regulation," while the California DMV stated last week it's working quickly but doesn't want to release a premature ruling. Reference Link
06:15 EDTMDRXAllscripts coverage transferred with an Outperform at RW Baird
Subscribe for More Information
06:07 EDTFOLDAmicus reports positive results in meetings with EMA and FDA
Amicus has met with regulatory authorities in Europe and the U.S. to discuss the approval pathways for the oral small molecule pharmacological chaperone migalastat HCl as a precision medicine monotherapy for Fabry patients who have amenable genetic mutations. The company held a meeting with the assigned European Rapporteurs to discuss the upcoming marketing authorization application for migalastat monotherapy. The Rapporteurs agreed that Amicus may submit its MAA for migalastat monotherapy under the Full Approval pathway in the EU and indicated support for Amicus to request Accelerated Assessment. Amicus is accelerating the timing of the MAA submission for full approval for migalastat monotherapy from the middle of 2015 to Q2. Amicus held a Type C meeting with the FDA and plans to submit an NDA for Accelerated Approval, for which the FDA is open to considering several potential surrogate endpoints evaluated in the clinical studies of migalastat. Amicus plans to schedule a pre-NDA meeting and to submit an NDA under Subpart H in 2H15
05:42 EDTGOOGeBay downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Gene Munster downgraded eBay (EBAY) to Underweight, the firm's sell-equivalent rating, saying competition from Google Wallet (GOOG), Apple Pay (AAPL), Facebook (FB) and Samsung will weigh on PayPal's valuation and market share over the next three years. Munster notes shares of eBay are up 12% since the beginning of February due to optimism around the PayPal spin-out. He cut his price target for shares to $49 from $55. The online marketplace and PayPal owner closed yesterday down $1.07 to $58.42.
March 18, 2015
18:32 EDTJBLOn The Fly: After Hours Movers
UP AFTER EARNINGS: Guess (GES), up 12.4% after reporting fourth quarter results and guidance... Shoe Carnival (SCVL), up 10%... NQ Mobile (NQ), up 9.1%... Tilly's (TLYS), up 1.3%... Cintas (CTAS), up 1.3% after reporting quarterly results and raising fiscal 2015 guidance. DOWN AFTER EARNINGS: Williams-Sonoma (WSM), down 4.1%... Jabil Circuit (JBL), down 1.8%... Juno Therapeutics (JUNO), down 3.3%. ALSO LOWER: Concert Pharmaceuticals (CNCE), down 4.4% after filing to sell common stock... Tekmira Pharmaceuticals (TKMR), down 3.7% after filing to sell 6M shares of common stock.
16:12 EDTJBLJabil Circuit backs FY15 core EPS view of $1.85-$2.15, consensus $2.03
Subscribe for More Information
16:10 EDTJBLJabil Circuit sees Q3 core EPS 43c-55c, consensus 47c
Subscribe for More Information
16:09 EDTJBLJabil Circuit reports Q2 core EPS 50c, consensus 45c
Subscribe for More Information
15:20 EDTJBLNotable companies reporting after market close
Subscribe for More Information
08:04 EDTGOOGAmerican Enterprise Institute to hold a discussion
Subscribe for More Information
07:28 EDTJBLJabil Circuit March volatility elevated into Q2 and outlook
Subscribe for More Information
06:04 EDTGOOGGoogle's initial drone design failed, company working on new drone, WSJ reports
Subscribe for More Information
05:59 EDTGOOGGoogle sees self-driving car on market within five years, Re/code says
Subscribe for More Information
05:55 EDTGOOGApple has small team working on augmented reality, says Piper Jaffray
Piper Jaffray analyst Gene Munster says that following talks with industry contacts, he believes Apple (AAPL) has a small team working and exploring the augmented reality space. Munster believes augmented reality has the potential to "be as profound a technology platform as the smartphone today," but admits broader consumer adoption is likely 10 years away. He views Apple's involvement in the space as an indication the company is preparing for the next evolution of computing. Munster has an Overweight rating on Apple with a $160 price target. He describes augmented reality as the "overlay of digital information on the physical world," with Google (GOOG) Glass given as an example.
05:43 EDTGOOGGoogle introduces new app approval process
Subscribe for More Information
March 17, 2015
14:13 EDTGOOGMorgan Stanley questions GM capital allocation plan
Subscribe for More Information
10:26 EDTFOLDOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTSDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTGOOGApple plans to allow trade-ins of Android, BlackBerry devices, Bloomberg says
Subscribe for More Information
09:14 EDTSDSandRidge Energy downgraded to Sell from Neutral at Global Hunter
Subscribe for More Information
09:07 EDTGOOGDISH's Sling TV launches on Xbox One
Subscribe for More Information
09:05 EDTGOOGMicrosoft Band now available at Best Buy, Target, Amazon, Re/code reports
Subscribe for More Information
07:42 EDTGOOGBoeing may produce satellite for tech giants, Reuters says
Subscribe for More Information
07:07 EDTGSKVeeva says selected by GlaxoSmithKline for multichannel CRM
Subscribe for More Information
07:06 EDTGSKVeeva selected by GSK as global multichannel CRM partner
Subscribe for More Information
06:37 EDTGOOGAfter losing marketshare, Google now asks Firefox users to switch, BI says
Subscribe for More Information
05:57 EDTGOOGChina vendors to ship 50M Androids with fingerprint sensors, DigiTimes reports
China vendors is expected to ship 50M Android (GOOG) smartphones with fingerprint sensors in 2015, reports DigiTimes. According to sources at Taiwan-based IC backend service companies, Android smartphone vendors have adopted sliding-type fingerprint sensors, which are more competitive in pricing compared to press-type sensors used by Apple (AAPL). Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use